Patent · US Active

6-cycloamino-3-(pyridazin-4-yl)imidazo[1,2-b]pyridazine and derivatives and pharmaceutical compositions comprising the same

US8455491B2 · kind B2 · utility

10Cited by

1References

15Claims

0Family size

Assignee

Sanofi · FR

Inventors

Frederic Puech · Rueil-Malmaison, FR
Yulin Chiang · Clay, US
Sylvain COTE DES COMBES · Mennecy, FR
Adrien Tak Li · Fontenay-aux-Roses, FR
Philippe Burnier · Maisons-Laffitte, FR

Key dates

Filing date	Jan 11, 2010
Grant date	Jun 4, 2013
Priority date	—
Expiry date	Jan 29, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D519/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to the 6-cycloamino-3-(pyridazin-4-yl)imidazo[1,2-b]pyridazine derivatives corresponding to general formula (I):Wherein R2, R7, R8, A, L and B are as defined herein. Also disclosed are the preparative methods and therapeutic use thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.